Recombinant Plasma Protein Therapeutics Market Insights, Forecast to 2025 (Bayer, Aptevo Therapeutics, Pharming Group, Pfizer, Etc.)
Recombinant plasma protein therapeutics market is driven by various factors such as shift from use of plasma-derived proteins to recombinant therapies, rise in awareness about rare disease management and increased focus on investments in rare diseases. Additionally, steady increase in the number of patients with rare hematological diseases and product approvals by regulatory authorities such as the Food and Drug Administration (FDA), European Commission, and Ministry of Health, Labour and Welfare (Japan) are anticipated to drive the market significantly during...
View full press release